This small-cap stock surged 75% since IPO price but ICICI Securities sets target below CMP; what should shareholders do?
ICICI Securities rate stocks including ICICI Bank.
· LiveMint Markets
Sudeep Pharma shares have climbed nearly 75% above their IPO price, but ICICI Securities says expectations for its emerging battery materials business are already reflected in the valuation. The brokerage retained its Hold rating while raising its target price to ₹1,000.
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Why it matters
- The shift to renewables is redrawing which energy names are structural winners versus stranded.
Market context
- Brokerage calls from ICICI Securities, with ratings on the stocks named. The stocks: ICICI Bank.
- Over three months: ICICI Bank -2.5% against Banks -6.0% (3.5 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| ICICI BankICICIBANK · Banks | ₹1,398.00 | +0.8% | +5.8% | -2.5% | -4.4% | 0.9× | — |
Banks
1M -3.4% · 3M -6.0%
ICICI Bank
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
No. 2 on Day 1: How Jio Platforms broke India’s market cap hierarchy on debut itself
Jio IPO: Which mutual funds bet big, and where did your SIP money go?
Acutaas Chemicals among 5 stocks hitting 52-week highs; rallied up to 18% in a month
Dean of valuation Aswath Damodaran pegs Anthropic's worth at $1.475 trillion ahead of mega IPO
Govt defends IDBI Bank valuation, says process added ₹3,917 cr to deal value